共 119 条
[1]
Moghadasi AN(2021)The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis Neurol Sci 42 3093-3099
[2]
Mirmosayyeb O(2022)Risk factors of severe COVID-19 in people with multiple sclerosis: a systematic review and meta-analysis Rev Neurol (Paris) 178 121-128
[3]
Barzegar M(2021)Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine N Engl J Med 384 403-416
[4]
Sahraian MA(2021)A global survey of potential acceptance of a COVID-19 vaccine Nat Med 27 225-228
[5]
Ghajarzadeh M(2022)COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis Neurol Sci 43 4085-4094
[6]
Etemadifar M(2006)MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis Mult Scler 12 769-774
[7]
Nouri H(2021)Pre-vaccination COVID-19 vaccine literacy in a Croatian adult population: a cross-sectional study Int J Environ Res Public Health 18 7073-536
[8]
Maracy MR(2022)COVID-19 vaccination uptake among individuals with immune-mediated inflammatory diseases in ONTARIO, CANADA, between December 2020 and October 2021: a population-based analysis J Rheumatol 49 531-e21
[9]
AkhavanSigari A(2022)Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis Mult Scler J Exp Transl Clin 8 20552173221102067-908
[10]
Salari M(2022)Perspectives and experiences with COVID-19 vaccines in people with MS Mult Scler J Exp Transl Clin 8 20552173221085242-655